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Abstract
Multiple experimental and human trials have shown that microcirculatory alterations are frequent in sepsis. In this
review, we discuss the characteristics of these alterations, the various mechanisms potentially involved, and the
implications for therapy. Sepsis-induced microvascular alterations are characterized by a decrease in capillary
density with an increased number of stopped-flow and intermittent-flow capillaries, in close vicinity to well-
perfused capillaries. Accordingly, the surface available for exchange is decreased but also is highly heterogeneous.
Multiple mechanisms may contribute to these alterations, including endothelial dysfunction, impaired inter-cell
communication, altered glycocalyx, adhesion and rolling of white blood cells and platelets, and altered red blood
cell deformability. Given the heterogeneous nature of these alterations and the mechanisms potentially involved,
classical hemodynamic interventions, such as fluids, red blood cell transfusions, vasopressors, and inotropic agents,
have only a limited impact, and the microcirculatory changes often persist after resuscitation. Nevertheless, fluids
seem to improve the microcirculation in the early phase of sepsis and dobutamine also can improve the
microcirculation, although the magnitude of this effect varies considerably among patients. Finally, maintaining a
sufficient perfusion pressure seems to positively influence the microcirculation; however, which mean arterial
pressure levels should be targeted remains controversial. Some trials using vasodilating agents, especially
nitroglycerin, showed promising initial results but they were challenged in other trials, so it is difficult to
recommend the use of these agents in current practice. Other agents can markedly improve the microcirculation,
including activated protein C and antithrombin, vitamin C, or steroids. In conclusion, microcirculatory alterations
may play an important role in the development of sepsis-related organ dysfunction. At this stage, therapies to
target microcirculation specifically are still being investigated.
Introduction
Sepsis is associated with high mortality. Multiple mechan-
isms may contribute to sepsis-associated organ dysfunc-
tion, which is related to altered tissue perfusion, especially
in the early stages, and to direct alterations in cellular
metabolism. The importance of rapid correction of perfu-
sion abnormalities has lead to the concept of early goal-
directed therapy, which has been shown to improve the
outcome of patients with septic shock [1]. However, even
when global hemodynamics are optimized, alterations in
the microcirculation can still be present and can contri-
bute to perfusion alterations [2]. Indeed, the microcircula-
tion is responsible for fine-tuning tissue perfusion and
adapting it to metabolic demand. Experimental and, more
recently with development of new techniques that allow
direct visualization of the microcirculation [3], clinical evi-
dence indicate that microcirculatory alterations occur in
severe sepsis and septic shock and that these alterations
may play a role in the development of organ dysfunction.
In this review, we will discuss the relevance of these
sepsis-associated microcirculatory alterations, the mechan-
isms involved in their development and potential
therapies.
Methods to evaluate microcirculation in humans
Several methods can be used to evaluate microcirculation
in septic patients [3]. Two techniques are currently used
to evaluate microcirculation at bedside: Sidestream Sark
Field imaging technique (SDF) and near infrared spectro-
scopy (NIRS). SDF is a small handheld microscope that
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layers. Vessels are visualized as the selected wavelength is
absorbed by the hemoglobin contained in the red blood
cells.
Orthogonal Polarization Spectral imaging technique
(OPS) was based on a similar principle but is no longer
available. The technique is limited by the fact that it can
only be applied on superficial tissues covered by a thin
epithelium (mostly the sublingual area) and it requires
collaboration or sedation of the patient. In addition,
great care should be taken to discard secretions and to
limit pressure artifacts.
NIRS utilizes near-infrared light to measure oxy- and
deoxy-hemoglobin in tissues and to calculate StO2 (tissue
oxygen saturation, measured by NIRS in thenar emi-
nence). In fact, StO2 represents the oxygen saturations of
all vessels with a diameter less than 1 mm (arterioles,
capillaries, and venules) comprised in the sampling
volume, with venules accounting for 75% of the blood
volume. Basal StO2 is of limited interest, because there is
a huge overlap between StO2 values obtained in septic
patients and in intensive care unit (ICU) controls or
healthy volunteers. StO2 also differs from central venous
O2 saturation (ScvO2) in sepsis. The analysis of changes
in StO2 during a brief episode of forearm ischemia enables
quantification of microvascular reserve. Several indices can
be measured, but the ascending slope, or recovery slope, is
the easiest to measure and is the most reproducible. At
the present time, both SDF and NIRS are mostly used for
research purposes.
Microcirculatory alterations are observed in severe sepsis
Multiple investigations in various experimental models
have shown that sepsis is associated with a decrease in
capillary density in association with increased heteroge-
neous perfusion in visualized capillaries, such that capil-
laries with intermittent or no flow are found in close
proximity to well-perfused capillaries [4-7]. Importantly,
capillaries in which there is no flow at a given time may be
well perfused a few minutes later, and perfused vessels
may later have no flow. The microcirculation is a very
dynamic process, and space and time heterogeneity are
increased in septic conditions. These alterations have been
observed in different models of sepsis, including those cre-
ated by administration of endotoxin or live bacteria and
bacterial peritonitis [5,6,8], in all organs investigated,
including the skin, tongue [6], gut [6,7], liver [4], and even
the brain [8], and in all species that have been investigated,
from rodents [5,9] to large animals [6,8]. Hence, these
changes seem to be ubiquitous and to have common
pathophysiologic mechanisms.
In patients with severe sepsis and septic shock, we first
demonstrated that microcirculatory perfusion is altered in
a similar way to that occurring in experimental conditions
[2]. Compared with healthy volunteers and ICU controls,
patients with severe sepsis have a decrease in vascular den-
sity together with an increased number of capillaries with
stopped or intermittent flow. Importantly, these alterations
can be fully reversed by topical application of acetylcho-
line, indicating that microthrombi are not an essential
component. Since this early study, more than 25 studies
from different teams around the world have shown similar
results (Table 1).
Relevance of sepsis-associated microcirculatory
alterations
Because the microcirculation is essentially adaptive, it is
important to understand whether the sepsis-associated
alterations are the primary event leading to cellular dys-
function or whether the changes in perfusion reflect
directly altered cellular metabolism (adaptive theory). In
experimental conditions, it has been possible to link
microvascular impairment to signs of tissue hypoxia:
colocalization of low PO2, production of hypoxia induci-
ble factor [10] or redox potential [11] with hypoperfused
vessels suggest that the altered perfusion leads to tissue
Table 1 Studies that have reported alterations in
sublingual microcirculation in patients with severe sepsis
and septic shock
Reference No. of
patients
Intervention
De Backer et al. AJRCCM 2002 50 Topical acetylcholine
Spronk et al. Lancet 2002 6 Nitroglycerin
Sakr et al. CCM 2004 49 Sequential
assessment
De Backer et al. CCM 2006 22 Dobutamine
De Backer et al. CCM 2006 40 Activated protein C
Creteur et al. ICM 2006 18 Dobutamine
Boerma et al. CCM 2007 23 Sequential
assessment
Trzeciak et al. Ann Emerg Med
2007
26 None
Sakr et al. CCM 2007 35 Transfusions
Trzeciak et al. ICM 2008 33 Goal directed therapy
Boerma et al. ICM 2008 35 None
Jhanji et al. ICM 2009 16 Norepinephrine
Dubin et al. Crit Care 2009 20 Norepinephrine
Buchele et al. CCM 2009 20 Hydrocortisone
Boerma et al. CCM 2010 70 Nitroglycerin
Ospina et al. ICM 2010 60 Fluids
Spanos et al. Shock 2010 48 None
Pottecher et al. ICM 2010 25 Fluids
Morelli et al. Crit Care 2010 40 Levosimendan
Ruiz et al. Crit Care 2010 12 High flow
hemofiltration
Dubin et al. J Crit Care 2010 20 Fluids
Morelli et al. ICM 2011 20 Terlipressin
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tion at the capillary end of well-perfused capillaries is
low, suggesting that the tissues are using the delivered
oxygen.
In septic patients, microcirculatory alterations are
more severe in nonsurvivors than in survivors [2]. By
sequentially assessing the sublingual microcirculation in
patients with septic shock, Sakr et al. [12] observed that
the microcirculation is rapidly improved in survivors,
whereas in nonsurvivors it remained disturbed, whether
these patients died from acute circulatory failure or
later, after resolution of shock, from organ failure. Simi-
lar results were recently observed in children with septic
shock [13]. Trzeciak et al. [14] also observed that early
(within 3 h) improvement of sublingual microcirculation
in response to resuscitation procedures was associated
with an improvement of organ function at 24 h, whereas
patients whose microcirculation did not improve experi-
enced a worsening of organ function.
Mechanisms involved in the regulation of
microcirculatory perfusion in normal conditions
Tissue perfusion is determined by vascular density–the
diffusive component–and by flow–the convective compo-
nent. Capillary density increases in response to chronic
hypoxia [15] or during training [16]. In exercise, the maxi-
mal oxygen consumption is proportional to muscle capil-
lary density. However, this adaptative process may take
several weeks to occur. In more acute situations, there is a
small reserve for capillary recruitment, mostly because a
few capillaries are shut down at baseline. Compared with
baseline, the heterogeneity of the microcirculation
increased by close to 10% during hypoxia or hemorrhage
[7].
How do capillary flow and density adapt in normal con-
ditions? In healthy conditions, the microcirculation is
responsible for fine-tuning of perfusion to meet local
oxygen requirements. This is achieved by recruiting and
derecruiting capillaries, shutting down or limiting flow in
capillaries that are perfusing areas with low oxygen require-
ments and increasing flow in areas with high oxygen
requirements. This process implies local control of flow,
which needs to be driven by backward communication.
Indeed, release of vasoactive or hormonal substances can
only lead to downstream adaptation, but it is upstream
adaptation that is required. Two mechanisms may help
with this local communication: perivascular sympathetic
nerves [17], which mostly influence the control of arteriolar
tone, and backward communication along the endothe-
lium, mediated by endothelial cells themselves. In addition,
red blood cells may act as intravascular sensors [18]. The
decrease in oxygen saturation that occurs as a result of
oxygen offloading causes the local release of nitric oxide,
leading to capillary dilation at the site where it is needed.
What drives blood flow in the capillaries? According to
Poiseuille’s law, flow in a capillary is proportional to the
driving pressure (ΔP) and to the fourth power of the
capillary radius (r), and inversely proportional to capillary
length (L) and blood viscosity (h):
Capillary ﬂow = πr4 P/8Lη
Because capillary length and viscosity cannot be
actively manipulated, capillary flow can only be adapted
by local dilation and increased driving pressure. Because
capillaries are situated downstream of resistive arterioles,
an increase in driving pressure can only be obtained by
vasodilation of resistive arterioles. Hence, in normal
conditions, the organism is continuously fine-tuning
microvascular density and flow by subtle dilation/con-
striction of selected arterioles and capillaries.
Importantly, it should be remembered that capillary
hematocrit is less than systemic hematocrit, due to the
necessary presence of a plasma layer at the endothelial
surface. Accordingly, hematocrit is proportional to capil-
lary radius, so vasodilation will markedly increase local
oxygen delivery as the result of a combined increase in
flow and in oxygen content.
Finally, it should be noted that adaptation of capillary
perfusion at the organ level does not depend on sys-
temic arterial pressure and cardiac output but, of course,
will result in increased cardiac output if venous return
increases as a result of a major increase in capillary
flow, as during exercise or feeding.
Mechanisms that may be involved in the development of
microcirculatory alterations in sepsis
Several mechanisms are implicated, including endothelial
dysfunction, altered balance between levels of vasocon-
strictive and vasodilating substances, glycocalyx altera-
tions, and interactions with circulating cells (Figure 1).
The crucial issue is to understand which are the major
mechanisms that contribute to the microvascular altera-
tions present in septic conditions and, more importantly,
whether these could be improved with therapy.
Multiple studies have shown that endothelial dysfunc-
tion occurs in sepsis, as evidenced by a decreased sensi-
tivity to vasoconstricting but also vasodilating agents.
However, most of these trials used large arteries, up to
first-order arterioles, and it is not known to what extent
the findings may apply to more distal arterioles and capil-
laries. In addition, communication between endothelial
cells may be altered. Experimentally, Tyml et al. [19]
showed that the communication rate between microves-
sels 500 microns apart was markedly impaired. The study
of postischemic hyperemia provides some indirect evi-
dence that endothelial dysfunction may play a role. Using
laser Doppler and NIRS techniques, several authors have
reported that the postischemic hyperemic response is
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are related to the severity of organ dysfunction [20] and
outcome [21].
The interaction between the endothelial surface and cir-
culating cells also is impaired in sepsis. First, the size of
the glycocalyx is markedly decreased [22]. The glycocalyx
is a layer of glucosaminoglycans that covers the endothe-
lial surface and in which various substances, such as
superoxide dismutase and antithrombin, are embedded.
The glycocalyx facilitates the flow of red blood cells and
limits adhesion of white blood cells and platelets to the
endothelium. Interestingly, destruction of the glycocalyx
layer by hyaluronidase can mimic sepsis-induced microcir-
culatory alterations [23].
Activation of coagulation may play a key role in the
pathogenesis of microcirculatory alterations [5,24]. In
mice challenged with endotoxin, fibrin deposition
occurred in a significant proportion of capillaries; the addi-
tion of anticoagulant factor decreased the number of non-
perfused capillaries, whereas the number was increased
after the addition of procoagulant factors [5]. However,
microthrombi formation is infrequently observed in
experimental sepsis [4].
Finally, circulating cells have a key role in these altera-
tions. Leukocyte rolling and adhesion to the endothelial
surface is increased in sepsis [4]. Importantly, this does
not only occur at the venular but also at the capillary
level [5]. In addition to locally contributing to further
activation of the coagulation and inflammatory cascades,
the presence of sticking or rolling leukocytes impairs the
circulation of other cells. Administration of selectins
decreased the adhesion and rolling of white blood cells
and improved microvascular perfusion [5]. Adhesion and
rolling of platelets also contributes to microcirculatory
alterations [4,5]. Finally, red blood cells can contribute to
microcirculatory alterations as a consequence of altera-
tions in red blood cell deformability [25], impaired
release of nitric oxide, and/or adhesion of red blood cells
to the endothelium [26].
Potential therapeutic interventions
It is crucial to understand that, given the heterogeneous
nature of the microvascular alterations, it is more impor-
tant to recruit the microcirculation than to increase total
flow to the organ. Ideally, the intervention should affect
one or several of the mechanisms involved in the develop-
ment of these microvascular alterations. Nevertheless,
most interventions that are currently used for their impact
on systemic hemodynamics also may somewhat influence
the microcirculation.
Interventions used to manipulate systemic hemodynamics
Fluids and vasoactive agents are key components of hemo-
dynamic resuscitation, with the goal of improving tissue
perfusion. However, improved cellular oxygen supply
implies an improvement in microvascular perfusion. Two
recent trials have demonstrated that fluids can improve
microvascular perfusion, increasing the proportion of per-
fused capillaries and decreasing perfusion heterogeneity
[27,28]. Importantly, in both trials the microcirculatory
Figure 1 Principal mechanisms implicated in the development of microcirculatory alterations.
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The microcirculatory effects of fluids seem to be mostly
present in the early phase of sepsis (within 24 h of diagno-
sis), whereas later (after 48 h) fluid administration failed to
improve the microcirculation even when cardiac output
increased [27]. Whether different types of fluid result in
different microvascular responses is still debated. In some
experimental conditions, colloids may increase microcir-
culatory perfusion more than crystalloids [29], but this dif-
ference has not been confirmed in septic patients [27].
The mechanisms by which fluids may improve the micro-
circulation are not well understood but may be related to
a decrease in viscosity, to a decrease in white blood cell
adhesion and rolling, or, indirectly, to a decrease in endo-
genous vasoconstrictive substances. Whether the effects of
fluids, when observed, will persist or be transient, and also
whether this effect can be “saturable,” i.e., only the initial
effects would be beneficial while further administration of
fluids would have minimal effect, requires further study.
This “saturable” effect is suggested by the observations of
Pottecher et al. [28] who reported that the first bolus of
fluids improved microvascular perfusion, whereas the sec-
ond had no effect even though cardiac output increased
further.
The effects of red blood cell transfusions also seem to
be quite variable. In one trial, although the effects in the
entire population were negligible, transfusions did
improve microvascular perfusion in patients with the
most severely altered microcirculation at baseline [30].
Beta-adrenergic agents have been shown to improve
microvascular perfusion, increasing not only convective
but also diffusive transport [31,32]. These effects were
dissociated form the systemic effects of these agents [31].
Because capillaries do not have beta-adrenergic receptors,
these effects may be mediated by a decrease in white
blood cell adhesion, as beta-adrenergic receptors are pre-
sent on the surface of white blood cells.
Vasopressor agents also have variable effects. Correction
of severe hypotension does not impair and may even
improve microvascular perfusion [33,34] probably through
the restoration of the perfusion of the organs through
achievement of a minimal perfusion pressure. However,
increasing blood pressure further (mean arterial pressure
from 65 to 75 and 85 mmHg) may fail to improve micro-
vascular perfusion. Of note, these data were obtained in
small cohort of patients and individual response was pro-
vided a huge interindividual variability was observed
[35,36]. Interestingly, the increase in arterial pressure
impaired the sublingual microcirculation in patients with
close to normal microcirculation at baseline, whereas it
was beneficial in the most severe cases [36].
Altogether, these data suggest that classical hemody-
namic interventions have variable effects on microvascu-
lar alterations in sepsis and that these effects cannot be
predicted from the evolution of systemic hemodynamics.
Often these alterations persist after systemic hemody-
namic optimization.
Other agents
Many other agents have been tested, especially in
experimental conditions. We will discuss the effects of
some of these agents, which either illustrate the implica-
tions of specific mechanisms affecting the microcircula-
tion or have promising effects.
Vasodilators
Because local constriction-dilation is implicated in the
regulation of flow and capillary recruitment and because
decreased vascular density and stopped-flow capillaries
may be the result of excessive vasoconstriction, vasodilat-
ing substances may have a role in manipulation of the
microcirculation. In patients with severe sepsis who have
severe microvascular alterations, we demonstrated that
topical administration of a large dose of acetylcholine, an
endothelium-dependent vasodilating agent, restored the
microcirculation to a state similar to that of healthy
volunteers and nonseptic ICU patients [2]. This observa-
tion has profound implications. First, sepsis-associated
microcirculatory alterations are functional and can be
totally reversed. Complete obstruction of microvessels by
clots is thus unlikely. Second, the endothelium may be
dysfunctional but is still able to respond to supraphysio-
logical stimulation. An important limitation of this find-
ing was that we were unable to ensure that excessive
vasodilation did not occur, leading to unnecessary high
perfusion to some areas with low metabolic rate. As the
agent was applied topically, perfusion pressure to the
organ was preserved; systemic administration of vasodi-
lating agents may not have the same effects.
In a small series of patients, Spronk et al. [37] reported
in a research letter that nitroglycerin administration
rapidly improved the microcirculation. These results were
challenged by a randomized trial that included 70 patients
with septic shock [38] and failed to show any difference in
the evolution of the microcirculation with nitroglycerin
compared to placebo. Does this second trial close the
issue? Probably not, as essential differences exist between
the studies. In particular, Spronk et al. [37] assessed the
microcirculation 2 min after administration of a bolus
dose of 0.5 mg of nitroglycerin while Boerma et al. [38]
evaluated the microcirculation 30 min after initiation of a
continuous infusion of 4 mg/h (0.07 mg/min). Dosing may
be crucial, as illustrated in cardiogenic shock [39], but one
should not neglect the fact that these effects may be very
transient. Finally, one should note that the microcircula-
tion was minimally altered at baseline in the trial by
Boerma et al. [38], as the proportion of perfused capillaries
was already normal (98%), leaving no room for further
improvement. Other vasodilating agents have been used,
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recently evaluated the effects of angiotensin converting
enzyme inhibition in an ovine model of septic shock. The
sublingual microcirculation was slightly less severely
altered in treated animals compared with controls, but
these effects were not accompanied by an improvement in
organ function. Accordingly, at this stage, the use of vaso-
dilating agents cannot be recommended. One of the rea-
sons for this relative failure is the lack of selectivity of
these agents, which dilate both perfused and nonperfused
vessels, thereby possibly leading to luxury perfusion of
some areas.
Anticoagulant agents
Activated protein C has repeatedly been shown to improve
the microcirculation in different experimental models and
in various organs [22,41,42]. Similar results were observed
in a controlled but not randomized trial, which showed
that the sublingual microcirculation improved already 4
hours after initiation of therapy, whereas it remained
stable in controls [43]. Similar beneficial results were
observed with antithrombin in experimental conditions
[44]. The anticoagulant effect seems not to be involved in
the microcirculatory effects of these agents. Indeed a mod-
ified antithrombin, deprived of its ligation site for the
endothelium but with preserved anticoagulant activity,
failed to improve the microcirculation in endotoxic ani-
mals [44]. In addition, hirudin, a pure thrombin inhibitor,
did not improve the microcirculation of septic animals
[45]. What then could be the mechanisms involved in the
beneficial effects of these agents? Decreased white blood
cell and platelet rolling and adhesion [41,42], preservation
of glycocalyx size [22], and improvement in endothelial
reactivity [46] are the most likely mechanisms.
Steroids
Hydrocortisone is frequently used as an adjunctive ther-
apy in patients with septic shock. Hydrocortisone facili-
tates weaning of vasopressor agents. Hydrocortisone may
induce some degree of arteriolar vasoconstriction and
this could alter capillary perfusion. It also may improve
endothelial function and thereby ameliorate the distribu-
tive defect. In healthy volunteers in whom endothelial
venular dilation is impaired by local cytokine infusion,
hydrocortisone administration can rapidly reverse this
phenomenon [47]. In 20 patients with septic shock,
Buchele et al. [48] observed that hydrocortisone
improved microvascular perfusion slightly. This effect
was already observed 1 hour after hydrocortisone admin-
istration and persisted during the entire observation per-
iod. Interestingly, these effects were independent of any
change in arterial pressure.
Among the proposed mechanisms, steroids may
improve endothelial function [47], preserve the glycoca-
lyx [49], or decrease rolling and adhesion of white blood
cells to the endothelium [50].
Vitamin C and tetrahydrobiopterin
Vitamin C and tetrahydrobiopterin have many impor-
tant actions, including the correct function of endothe-
lial nitric oxide synthase. Deficiency of both these
substances may occur in sepsis. In rodents, administra-
tion of vitamin C improved microcirculatory perfusion,
increasing capillary density and decreasing the number
of stopped flow capillaries [9,51]. Importantly these
beneficial results persisted even when vitamin C was
administered up to 24 h after the initiation of sepsis
[9]. Similar beneficial effects have been observed with
tetrahydrobiopterin [5,51]. These promising results
need to be confirmed in large animal models and in
humans.
Conclusions
Multiple experimental and clinical trials have shown that
microcirculatory alterations occur in sepsis and that these
may play a role in the development of organ dysfunction.
These alterations are characterized by a decrease in capil-
lary density and in heterogeneity of capillary perfusion
with stopped-flow capillaries in close vicinity to well-per-
fused capillaries. Various mechanisms can be implicated in
the development of these alterations, including endothelial
dysfunction and failure of communication between
endothelial cells, glycocalyx alterations, and altered inter-
actions between the endothelium and circulating cells.
Given the heterogeneous aspect of microcirculatory perfu-
sion and the mechanisms involved in the development of
these alterations, it is expected that classical hemodynamic
interventions will only minimally affect the microcircula-
tion. Vasodilating agents have been suggested to influence
the microcirculation, but their administration may be lim-
ited by the risk of hypotension and their lack of selectivity,
potentially leading to luxury perfusion. Other interven-
tions are currently in the pipeline, most of these aimed at
modulating endothelial function.
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